Published in Cancer Treat Rep on July 01, 1978
Trials to assess equivalence: the importance of rigorous methods. BMJ (1996) 9.29
Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial. BMJ (1998) 3.90
Effectiveness of appropriately trained nurses in preoperative assessment: randomised controlled equivalence/non-inferiority trial. BMJ (2002) 2.48
Dictated versus database-generated discharge summaries: a randomized clinical trial. CMAJ (1999) 2.28
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. J Clin Oncol (2008) 1.87
Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone? Ann Rheum Dis (1988) 1.69
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. J Clin Oncol (2008) 1.25
Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob Agents Chemother (2009) 1.21
Randomized, double-blind comparison of single-dose regimens of rufloxacin and pefloxacin for acute uncomplicated cystitis in women. French Multicenter Urinary Tract Infection-Rufloxacin Group. Antimicrob Agents Chemother (1995) 1.20
Noninferiority and equivalence designs: issues and implications for mental health research. J Trauma Stress (2008) 1.20
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1991) 1.19
A randomised controlled trial to test equivalence between retinyl palmitate and beta carotene for vitamin A deficiency. BMJ (1993) 0.90
Recruitment, follow-up and analysis times in clinical trials of cancer treatment: a case study. Br J Cancer (1990) 0.79
Classification of parietal pleural invasion at adhesion sites with surgical specimens of lung cancer and implications for prognosis. Virchows Arch (2005) 0.78
Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients. Asian J Androl (2012) 0.76
Testing of Hypothesis in Equivalence and Non Inferiority Trials-A Concept. J Clin Diagn Res (2016) 0.75
Noninferiority trial design and analysis with an ordered three-level categorical endpoint. J Biopharm Stat (2009) 0.75
Intravenous immune globulin in the Guillain-Barré syndrome. Clin Exp Immunol (1994) 0.75
A placebo-controlled study of interaction between nabumetone and acenocoumarol. Br J Clin Pharmacol (1999) 0.75
Short-term intravenous antimicrobial prophylaxis for elective rectal cancer surgery: results of a prospective randomized non-inferiority trial. Surg Today (2013) 0.75
Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 29.80
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53
Flexible regression models with cubic splines. Stat Med (1989) 14.45
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Signaling of cell fate decisions by CLAVATA3 in Arabidopsis shoot meristems. Science (1999) 8.61
Data management and analysis for gene expression arrays. Nat Genet (1998) 8.60
The CONSTANS gene of Arabidopsis promotes flowering and encodes a protein showing similarities to zinc finger transcription factors. Cell (1995) 7.76
Dependence of stem cell fate in Arabidopsis on a feedback loop regulated by CLV3 activity. Science (2000) 6.05
Plasmid vectors for the genetic analysis and manipulation of rhizobia and other gram-negative bacteria. Methods Enzymol (1986) 5.58
High frequency mobilization of gram-negative bacterial replicons by the in vitro constructed Tn5-Mob transposon. Mol Gen Genet (1984) 5.35
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68
The potential for improved teamwork to reduce medical errors in the emergency department. The MedTeams Research Consortium. Ann Emerg Med (1999) 4.59
Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst (1998) 4.32
Statistical aspects of prognostic factor studies in oncology. Br J Cancer (1994) 4.22
Bayesian variable selection method for censored survival data. Biometrics (1998) 3.84
Testing for qualitative interactions between treatment effects and patient subsets. Biometrics (1985) 3.71
A molecular link between stem cell regulation and floral patterning in Arabidopsis. Cell (2001) 3.55
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22
Randomized phase II clinical trials. Cancer Treat Rep (1985) 3.19
A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer. J Natl Cancer Inst (2000) 2.95
A new family of RSF1010-derived expression and lac-fusion broad-host-range vectors for gram-negative bacteria. Gene (1990) 2.89
Clinical trial designs for cytostatic agents: are new approaches needed? J Clin Oncol (2001) 2.82
Demonstration of high-fidelity simulation team training for emergency medicine. Acad Emerg Med (1999) 2.82
Extension of the host range of Escherichia coli vectors by incorporation of RSF1010 replication and mobilization functions. J Bacteriol (1985) 2.70
Simulation based teamwork training for emergency department staff: does it improve clinical team performance when added to an existing didactic teamwork curriculum? Qual Saf Health Care (2004) 2.60
Evidence that dyslexia may represent the lower tail of a normal distribution of reading ability. N Engl J Med (1992) 2.59
Confidence intervals for reporting results of clinical trials. Ann Intern Med (1986) 2.49
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer (2006) 2.45
High-frequency conjugal plasmid transfer from gram-negative Escherichia coli to various gram-positive coryneform bacteria. J Bacteriol (1990) 2.42
The Comprehensive assessment and Referral Evaluation (CARE)--rationale, development and reliability. Int J Aging Hum Dev (1977) 2.35
The development of plasmid-free strains of Agrobacterium tumefaciens by using incompatibility with a Rhizobium meliloti plasmid to eliminate pAtC58. Plasmid (1985) 2.33
A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet (1994) 2.30
Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J (1997) 2.27
Length biased sampling in etiologic studies. Am J Epidemiol (1980) 2.23
Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol (1999) 2.22
Statistical model to determine the relationship of response and survival in patients with advanced ovarian cancer treated with chemotherapy. J Natl Cancer Inst (1992) 2.16
Efficacy of selected diagnostic tests for sexually transmitted diseases. JAMA (1976) 2.15
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med (1999) 2.11
A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Stat Med (1984) 2.06
Measures of explained variation for survival data. Stat Med (1990) 2.06
Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993--the perspective of NIH clinical trialists. Control Clin Trials (1995) 2.04
On the efficiency of targeted clinical trials. Stat Med (2005) 1.99
Practical Bayesian guidelines for phase IIB clinical trials. Biometrics (1994) 1.99
Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med (1981) 1.92
Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep (1986) 1.91
Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. J Natl Cancer Inst (1991) 1.85
Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep (1977) 1.82
Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditions. Cancer Causes Control (1998) 1.78
Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol (1999) 1.77
Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol (1999) 1.76
Assessing whether to perform a confirmatory randomized clinical trial. J Natl Cancer Inst (1996) 1.76
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol (1998) 1.71
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71
The Norton-Simon hypothesis revisited. Cancer Treat Rep (1986) 1.70
Genetics of xanthan production in Xanthomonas campestris: the xanA and xanB genes are involved in UDP-glucose and GDP-mannose biosynthesis. J Bacteriol (1992) 1.68
Statistical design of reverse dye microarrays. Bioinformatics (2003) 1.68
Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis. J Natl Cancer Inst (1993) 1.66
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene (2007) 1.63
Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med (1973) 1.61
Parallels between UNUSUAL FLORAL ORGANS and FIMBRIATA, genes controlling flower development in Arabidopsis and Antirrhinum. Plant Cell (1995) 1.60
Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina. Circulation (2002) 1.56
Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute. J Clin Oncol (1997) 1.56
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54
The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med (1978) 1.54
Why predictive indexes perform less well in validation studies. Is it magic or methods? Arch Intern Med (1987) 1.51
Comparison of microarray designs for class comparison and class discovery. Bioinformatics (2002) 1.51
Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms ("dilated coronopathy"). J Am Coll Cardiol (1999) 1.50
Bayesian subset analysis. Biometrics (1991) 1.50
Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? Circulation (1999) 1.50
Are placebo-controlled clinical trials ethical or needed when alternative treatment exists? Ann Intern Med (2000) 1.47
A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis. Stat Med (1996) 1.44
Carvedilol for prevention of restenosis after directional coronary atherectomy : final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation (2000) 1.43
Smoking abstinence and small cell lung cancer survival. An association. JAMA (1980) 1.43
Bicaval versus atrial anastomoses in cardiac transplantation. Right atrial dimension and tricuspid valve function at rest and during exercise up to thirty-six months after transplantation. J Thorac Cardiovasc Surg (1994) 1.41
Identification of Rhizobium plasmid sequences involved in recognition of Psophocarpus, Vigna, and other legumes. J Cell Biol (1986) 1.41
Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer (2009) 1.40
Predicting the course of Gompertzian growth. Nature (1976) 1.39
Restricted randomization designs in clinical trials. Biometrics (1979) 1.38
Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery (1996) 1.38
Dual role for fimbriata in regulating floral homeotic genes and cell division in Antirrhinum. EMBO J (1997) 1.38
Methodologic guidelines for reports of clinical trials. Cancer Treat Rep (1985) 1.38
Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors. J Natl Cancer Inst (2000) 1.37
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res (1979) 1.35
Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res (2000) 1.35
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep (1979) 1.35
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol (2000) 1.34
KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene (2006) 1.29
Prognostic factors in Burkitt's lymphoma: importance of total tumor burden. Cancer (1980) 1.29
Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med (1979) 1.28
Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg (1985) 1.27
Long-term second remissions in acute lymphatic leukemia. Cancer (1975) 1.27
Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treat Rep (1979) 1.27
Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition. Cancer (1988) 1.26
Cloning and analysis of a 35.3-kilobase DNA region involved in exopolysaccharide production by Xanthomonas campestris pv. campestris. J Bacteriol (1990) 1.26
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol (2001) 1.26
High tibial osteotomy and ligament reconstruction in varus angulated, anterior cruciate ligament-deficient knees. A two- to seven-year follow-up study. Am J Sports Med (1993) 1.24